In 2023, global birth rates dipped by 1.15% per 1000 people, with significant declines noted in the EU (5.9%) and China (2.3%), extending a five-year trend. Consequently, all stages of infant formula production, from birth to growing milk, have declined. As a result, Clover Corporation (ASX: CLV), an Aussie tech company specialising in infant formula
Read More
Nutritional ingredients producer Clover Corporation (ASX: CLV) witnessed a slight surge in its FY23 revenue, even as it battled growing inflation and falling demand, especially from China’s dwindling birth rates which hit a record low last year. Clover achieved an increase in revenue, reaching $79.9 million in FY23, up from FY22’s $70.7 million. However, this
Read More
China seems to be the hot spot for infant milk formula companies, as Clover Corporation(ASX: CLV) becomes yet another Aussie company to launch its product there successfully. As international borders reopened, the Company delivered nearly $41 million as sales rebounded and key infant milk manufacturers order volumes lifted. In FY22, the Company saw a revenue
Read More
Babies born before 37 weeks of pregnancy are considered premature, and often are at risk of getting sick or suffering developmental issues. Multiple studies have confirmed that there is an interplay between prematurity and childrens’ intelligence quotient (IQ). Premature babies often have lower IQs than their full term peers. To help premature babies reach their
Read More